Current overview and special considerations for second breast cancer in Hodgkin lymphoma survivors

•SBC risk is influenced by age at HL treatment, follow-up latency, radiation field, and dose irradiation.•Limiting radiotherapy fields and doses may reduce SBC risk, but it still remains higher.•Breast screening among HL survivors permits early detection .•Survivors are unware of SBC risks and oncologists are not familiar with surveillance guidelines. Second breast cancer (SBC) is the most common solid cancer among Hodgkin Lymphoma (HL) female survivors. We reviewed the related modifying risk factors, radiation-induced carcinogenesis, tumors characteristics, management specificities, prevention and surveillance modalities based on current evidence. The risk of developing SBC may be influenced essentially by the age at HL treatment, follow-up latency, dose of irradiation received and the extent of irradiated field. SBCs generally develop at younger age, they are often bilateral, and exhibit more aggressive biological features and worse prognosis. No firm answer about the benefits of breast surveillance is provided by literature, but compelling evidence tends toward a clinical benefit in early detection. Increasing awareness among health providers’ care and current survivors as well as the implementation of screening measures is crucial. Great efforts are ongoing in individualizing treatment strategies for future HL patients and response-adapted approaches are holding promise in prevention of these second malignancies.